Sassy69
New member
This was interesting today:
http://www.cbsnews.com/stories/2004/12/02/earlyshow/contributors/emilysenay/main658687.shtml
Booster Mulled For Sex Desire
NEW YORK, Dec. 2, 2004
Food and Drug Administration advisers are scheduled on Thursday to review Procter and Gamble's Intrinsa, which could be the first prescription medication to win approval for female sexual dysfunction.
"What we're talking about," says The Early Show medical correspondent Dr. Emily Senay, "is a new form of testosterone replacement therapy for women who suffer from sexual problems after they have their ovaries removed.
"We usually think of testosterone as the male hormone, but women also produce a small amount in their ovaries. When testosterone levels drop in women, some experience a drop in sexual desire."
Senay explains that, "Intrinsa is delivered by a patch. The idea is to replace lost testosterone and improve sexual desire. The patch slowly releases testosterone into the blood stream. It's replaced twice a week, and it takes about four weeks for women to start to notice a difference.
"Studies show that the patch restored sexual desire in many post-menopausal women who had their ovaries removed," Senay continued. "Another product which delivers testosterone in gel form is also in the pipeline.
She cautions that, "The term 'female Viagra' doesn't accurately reflect what the medication does. Intrinsa works very differently than male impotence drugs like Viagra and other drugs for erectile dysfunction. Viagra does not increase a man's interest in sex, it improves his performance. Intrinsa increases a woman's desire for sex. Also, unlike Viagra and similar drugs that are only taken when needed, wearing the patch is a longer-term commitment."
It must be worn at all times, Senay points out.
"If approved," she adds, "this drug will not be available for all women with sexual dysfunction. Intrinsa was tested on women who had low testosterone because their ovaries had been removed, and the FDA is deciding whether to approve it for this specific group of women.
"Further study is needed on the drug's usefulness for the much larger population of naturally-menopausal women who lose testosterone as they age and experience sexual problems," but still have their ovaries.
In addition, says Senay, "This will not work for women who have sexual dysfunction due to psychological factors or a physiological reason not related to testosterone. It won't help women who have a low sex drive due to depression or relationship problems, for instance."
P&G says, if the drug is approved, it would be made available in the first half of next year.
http://www.cbsnews.com/stories/2004/12/02/earlyshow/contributors/emilysenay/main658687.shtml
Booster Mulled For Sex Desire
NEW YORK, Dec. 2, 2004
Food and Drug Administration advisers are scheduled on Thursday to review Procter and Gamble's Intrinsa, which could be the first prescription medication to win approval for female sexual dysfunction.
"What we're talking about," says The Early Show medical correspondent Dr. Emily Senay, "is a new form of testosterone replacement therapy for women who suffer from sexual problems after they have their ovaries removed.
"We usually think of testosterone as the male hormone, but women also produce a small amount in their ovaries. When testosterone levels drop in women, some experience a drop in sexual desire."
Senay explains that, "Intrinsa is delivered by a patch. The idea is to replace lost testosterone and improve sexual desire. The patch slowly releases testosterone into the blood stream. It's replaced twice a week, and it takes about four weeks for women to start to notice a difference.
"Studies show that the patch restored sexual desire in many post-menopausal women who had their ovaries removed," Senay continued. "Another product which delivers testosterone in gel form is also in the pipeline.
She cautions that, "The term 'female Viagra' doesn't accurately reflect what the medication does. Intrinsa works very differently than male impotence drugs like Viagra and other drugs for erectile dysfunction. Viagra does not increase a man's interest in sex, it improves his performance. Intrinsa increases a woman's desire for sex. Also, unlike Viagra and similar drugs that are only taken when needed, wearing the patch is a longer-term commitment."
It must be worn at all times, Senay points out.
"If approved," she adds, "this drug will not be available for all women with sexual dysfunction. Intrinsa was tested on women who had low testosterone because their ovaries had been removed, and the FDA is deciding whether to approve it for this specific group of women.
"Further study is needed on the drug's usefulness for the much larger population of naturally-menopausal women who lose testosterone as they age and experience sexual problems," but still have their ovaries.
In addition, says Senay, "This will not work for women who have sexual dysfunction due to psychological factors or a physiological reason not related to testosterone. It won't help women who have a low sex drive due to depression or relationship problems, for instance."
P&G says, if the drug is approved, it would be made available in the first half of next year.